statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	476
RU - Federazione Russa	253
SG - Singapore	172
CN - Cina	116
BR - Brasile	86
GB - Regno Unito	81
VN - Vietnam	43
DE - Germania	40
IT - Italia	39
FR - Francia	29
HK - Hong Kong	28
SE - Svezia	28
FI - Finlandia	26
IE - Irlanda	21
KR - Corea	13
AR - Argentina	8
UA - Ucraina	8
CA - Canada	7
MX - Messico	6
PL - Polonia	6
ZA - Sudafrica	6
JP - Giappone	5
BD - Bangladesh	4
IQ - Iraq	4
NG - Nigeria	4
TR - Turchia	4
CL - Cile	3
ID - Indonesia	3
NL - Olanda	3
AT - Austria	2
AU - Australia	2
CZ - Repubblica Ceca	2
DO - Repubblica Dominicana	2
GE - Georgia	2
IN - India	2
KH - Cambogia	2
PK - Pakistan	2
TH - Thailandia	2
AL - Albania	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BJ - Benin	1
CH - Svizzera	1
CO - Colombia	1
CY - Cipro	1
EC - Ecuador	1
EG - Egitto	1
ES - Italia	1
HR - Croazia	1
KE - Kenya	1
KG - Kirghizistan	1
KW - Kuwait	1
KZ - Kazakistan	1
LB - Libano	1
MA - Marocco	1
MY - Malesia	1
NI - Nicaragua	1
OM - Oman	1
PE - Perù	1
PH - Filippine	1
PY - Paraguay	1
RO - Romania	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
TG - Togo	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
UZ - Uzbekistan	1
ZW - Zimbabwe	1
Totale	1.571

Nome	#
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up	184
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient	172
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients	171
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients	163
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials	138
Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation	134
Treatment of chronic pulmonary aspergillosis with voriconazole: review of a case series	134
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up	132
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings	127
High-dose or Multi-day Praziquantel for Imported Schistosomiasis? A Systematic Review	121
VIROLOGICAL EFFICACY OF A REDUCED DOSE OF NEVIRAPINE IN A SMALL COHORT OF SUPPRESSED HIV-1-INFECTED PATIENTS	118
Totale	1.594

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	10	0	0	0	0	0	0	0	0	0	5	5	0
2021/2022	68	6	34	1	3	0	0	0	3	1	0	3	17
2022/2023	164	10	19	18	33	11	36	2	11	18	0	3	3
2023/2024	93	5	10	12	11	13	9	2	8	1	2	9	11
2024/2025	239	9	12	9	49	9	5	13	2	44	15	18	54
2025/2026	750	43	66	45	134	220	44	55	24	83	36	0	0
Totale													1.594

CATALOGO DEI PRODOTTI DELLA RICERCA